Shares of Moderna climbed more than 3% on Friday. Get top local stories in DFW delivered to you every morning with NBC DFW's News ... agreement. In an interview, Moderna Chief Financial Officer ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic insider stock purchases by the CEO and director. This comes as a significant ...

Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences and the appointment of vaccine skeptic Robert F. Kennedy Jr.

In an interview, Moderna Chief Financial Officer Jamey Mock said one of the most important takeaways from the company's full-year 2024 results is that it reduced costs by 27% compared to 2023.

After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter Inventory write-downs and manufacturing charges are nothing new for Moderna, which has struggled ...

就在最近，Moderna首席执行官斯特凡·班塞尔（Stephane Bancel）以每股31.04美元的大手笔增持了公司股票，总额接近500万美元。这一增持引发市场强烈反响，股价在美股盘后交易中一度上涨近5%。对于这样一个备受瞩目的举动，背后的深意值得投资者们深思。 CEO增持 ...

Looking ahead to 2025, Moderna expects revenue of $1.5bn to $2.5bn, with the cost of sales expected to be around $1.2bn. Moderna CEO Stéphane Bancel stated: “We have made progress in 2024 across our ...

Shares of Moderna climbed more than 3% on Friday. Get top local stories in Connecticut delivered to you every morning. Sign up for NBC ... In an interview, Moderna Chief Financial Officer Jamey ...